MedPath

Antibacterial Photodynamic Therapy as an Adjunctive Treatment on Oral Hygiene in Elderly Persons

Not Applicable
Recruiting
Conditions
Dental Plaque
Oral Complication
Bleeding of Subgingival Space
Interventions
Device: Lumoral Treatment
Behavioral: Standard oral hygiene methods
Registration Number
NCT06576063
Lead Sponsor
Koite Health Oy
Brief Summary

On average, the dental condition of elderly people is poor due to various reasons. The importance of oral health maintenance of the ageing population has been recognized by the World Health Organization (WHO), as oral health plays a key role in reaching the global goal of the "Decade of Healthy Ageing 2021-2030".

New measures for maintaining good oral health are welcome. The use of antibacterial photodynamic therapy (aPDT) and antibacterial blue light (aBL) has been studied and found to reduce the amount of plaque in the mouth. The Lumoral device is a CE-marked home medical device combining aPDT and aBL, and it is effective in reducing the development of plaque and harmful bacteria in the plaque. The device has also been shown to be easy and safe to use. In this study, we are combining the importance of regular dental appointments with the importance of enhanced dental self-care, to bring one regional solution for reaching the global goal set by WHO.

Detailed Description

The ageing population is increasing rapidly worldwide. In the year 2000, there were 69 million people over the age of 80 in the world (United Nations, 2003), and it is estimated that by the year 2030, 1 out of 6 persons will be 60 years of age or more worldwide (World Health Organization, 2022). The proportion of the ageing population having their natural teeth left is also increasing. In Finland, the average number of toothless people aged over 65 has decreased from 44% measured in the year 2000 to 21% in 2011. (Suominen et al., 2012, Suominen et al., 2018).

As people get older, their ability to function deteriorates, and the elderly, especially those living in roundthe-clock care, have been found to have shortcomings in maintaining oral hygiene (Hiltunen et al., 2020). 4 Toothlessness is reduced in the elderly population living in care homes, too. According to a Study in Finland, in 2003, 52 % of inhabitants were toothless in enhanced service housing, and in 2017, the proportion of toothless had decreased to 38% (Saarela et al., 2020). In 2017-2018, inhabitants of elderly care homes had an average of 13.8 teeth. Only a small proportion of the population had clean teeth, and the worse the level of oral hygiene, the worse the quality of life (Saarela et al., 2021).

The World Health Organization has proposed a "Decade of Healthy Ageing 2021-2030" action plan to encourage countries to develop and implement policies and programmes to promote healthy ageing and improve the quality of life in the older population (WHO 2020). While there is an interrelation between oral and systemic health, periodontal health has been linked to several chronic systemic conditions such as diabetes and cardiovascular diseases via shared inflammatory pathways. Good oral health enables daily functions like eating and speaking, while tooth loss, hyposalivation and other oral conditions obstruct oral functions and make nutritional intake more difficult. Bad oral condition also affects social interaction and quality of life. As oral functioning declines, it is associated with a decline in general function and weakness in the older population, and it can eventually lead even to disability and loss of independence. Therefore, the World Health Organization together with the FDI World Dental Federation have recognized the importance of oral health maintenance and functioning to enable healthy ageing in older adults (Chan et al., 2023).

The dental condition of elderly persons is often poor. Cavities and dental connective tissue disease are relatively common in persons of 75 and older. Untreated oral infections predispose elderly people to pneumonia, among other complications (Nishizawa et al., 2019). Chronic oral infectious diseases, and sometimes fatal complications, are preventable with good oral hygiene. Regular cleaning of the mouth and teeth from plaque is still the most important thing for keeping the mouth healthy. According to Siukosaari and Nihtilä (2015), one third of the aged population in Finland suffers from dry mouth due to various illnesses or the use of many medications. Lack or reduction of saliva may predispose to inflammatory diseases in the mouth. If multiple medications are in use simultaneously, the dry mouth symptoms may even worsen (Siukosaari et al., 2015).

The use of antibacterial photodynamic therapy (aPDT) and antibacterial blue light, as adjunctive treatments to standard oral home care has been studied and found to reduce the amount of plaque in the mouth (Nikinmaa et al., 2021a). The Lumoral device is a CE class IIa -marked medical device for home use that is effective in reducing the development of plaque and harmful bacteria in the plaque (Pakarinen et al., 2022; Lähteenmäki et al., 2022). The performance of the device is based on the aPDT method, in which the photosensitive substance in the Lumorinse mouthwash attaches to the bacterial coating and is activated as an antibacterial by light, https://lumoralpro.com/pages/how-it-works. The antibacterial effect is applied directly to the plaque, reducing the impact on the normal oral flora. Preliminary studies have found that the method reduces inflammatory factors in periodontitis. (Pakarinen et al., 2022). In addition, the heat produced by the device also enhances saliva production, which also affects maintaining good oral health (Dodds, et al., 2015). Unpublished data from a randomized clinical trial conducted by the University of Helsinki in which Lumoral was used by the residents of elderly 24-hour care also showed that the device was safe to use, and it had a significant impact on oral health measured by the Community Periodontal Index (Saarela et al., 2023).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • An elderly (age ≥ 65 years) person living at home or at care home, with a possibility to regular dental care appointments
  • Ability to understand and sign the informed consent
  • At least 10 teeth in the mouth, including implants
  • Ability to understand and follow the study protocol, including tooth brushing and following the instructions for the use of Lumoral Treatment, based on the assessment of the investigator
Exclusion Criteria
  • Uncontrolled diabetes mellitus (DM)
  • Severe dementia or other similar conditions that may restrict understanding of the study information and protocol
  • Presence of any physical limitation or restriction that might restrict Lumoral use
  • Active smoking and use of other tobacco products
  • Use of antibiotics within 4 weeks week prior study
  • Oral thrush
  • Known sensitivity to near-infrared or antibacterial blue light.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Study groupLumoral TreatmentStandard oral hygiene methods and adjuvant use of Lumoral Treatment device
Control groupStandard oral hygiene methodsStandard oral hygiene methods
Study groupStandard oral hygiene methodsStandard oral hygiene methods and adjuvant use of Lumoral Treatment device
Primary Outcome Measures
NameTimeMethod
Bleeding on probing (BOP)9 months

Change in the inflammatory parameter BOP.A full-mouth assessment at six sites per tooth (mesiobuccal, buccal, distobuccal, mesiolingual, lingual, distolingual). Gingival bleeding is considered as positive if bleeding occurs within 15 seconds after gentle probing with a probe at the sulcus. Dichotomous scoring to each site of the tooth as bleeding "1 present" and "0 absent". BOP is reported as the percentage (%) of sites with positive findings.

Calculation formula: number of bleeding sites/ 6 times number of teeth.

Secondary Outcome Measures
NameTimeMethod
Plaque index (RMNPI)9 months

Assessment of six index teeth, measured at four sites per tooth

* Dichotomous scoring to each site of the tooth as plaque "1 present" and "0 absent"

* RMNPI reported as the percentage (%) of sites with plaque

* Calculation formula: number of sites with plaque/ 4 times number of teeth

Periodontal Pocket Depth (PPD)9 months

A full-mouth assessment, measured at six sites per tooth. Assessed from the base of the pocket to the gingival margin (mm)

Active matrix metalloproteinase 8 (aMMP-8)9 months

Change in periodontal inflammation marker aMMP-8. The oral rinse fluid sample collection and the aMMP-8 marker analysis will be performed using Periosafe test (Dentognostics GmbH) according to the manufacturer's instructions.

Oral Bacterial flora9 months

Quantification of periodontopathic bacteria by 16S rRNA sequencing analysis

- Microbiological samples can be collected using Iso Taper Paper Points, size-20 (VDW GmbH) from selected gingival/periodontal pockets with maximum initial probing depth. The paper points can be placed into sterile, small-aliquot containers, and immediately stored at -20°C until analysis

Dryness of Mouth (DOM)9 months

Clinical, visual assessment of oral mucosal moisture/dryness:

0 points: Saliva secretion appears normal (saliva serous, runny)

1. point: Oral mucosa shiny and tight; and/or saliva foamy or mucousy; and or only a little clear saliva at the bottom of mouth

2. points: Mouth completely dry, mirror sticks to cheek or tongue, mucous membranes often reddened; and/or knuckles on the surface of the tongue have disappeared; and/or mouth appears carstic

OHIP-14 questionnaire9 months

Measures people's perception of the social impact of oral disorders on their well-being.

Fourteen items of OHIP are divided into seven dimensions: functional limitation, physical discomfort, psychological discomfort, physical disability, psychological disability, social disability, and handicaps. Responses are made on a 5-point scale (from 0 = never, to 4 = very often).

Adverse events9 months

Any suspicion of an adverse event related to the investigational device, the treatment method, or the study protocol.

Trial Locations

Locations (2)

SuperSuu

🇫🇮

Sipoo, Uusimaa, Finland

KotiHammas

🇫🇮

Vantaa, Uusimaa, Finland

© Copyright 2025. All Rights Reserved by MedPath